John M. TiltonAssociateSheppard, Mullin, Richter & Hampton LLPWebsitewww.sheppardmullin.comOrganization ProfileFull ProfileConnectEmail424-288-5317 Professional Biography John M. Tilton is an associate in the Corporate Practice group in the firm's Century City office. Education J.D., University of California, Los Angeles, 2018 B.A., Hillsdale College, 2014 Admissions California More Legal and Business Bylines From John M. Tilton District Court Elucidates the Meaning of “to Induce” Under the Federal Health Care Program Anti-Kickback Statute - (Posted On Thursday, February 29, 2024) Medicare Advantage RADV Audit Final Rule Challenged in Court - (Posted On Thursday, September 28, 2023) CMS Announces Changes to ACO REACH Model - (Posted On Monday, September 11, 2023) Get Prepared – Newly Mandated Cultural Competency Training for Illinois Healthcare Providers - (Posted On Thursday, August 31, 2023) CMS Announces Proposed Rule for 2024 Medicare Physician Fee Schedule - (Posted On Friday, August 11, 2023) Supreme Court Clarifies that Subjective (Not Objective) Knowledge of Falsity of Claim Dictates False Claims Act Liability - (Posted On Friday, June 02, 2023) PE Firms Face Liability for the Conduct of their Portfolio Companies: Are you Paying Attention? - (Posted On Monday, April 03, 2023) CMS Issues Long-Awaiting Medicare Advantage RADV Final Rule - (Posted On Wednesday, March 01, 2023) CMS Issues Long-Awaited Medicare Advantage RADV Final Rule - (Posted On Wednesday, February 01, 2023) CMS Pushes Publication of Final FFS Adjuster for RADV Audits Rule to February 1, 2023 - (Posted On Tuesday, November 01, 2022) Pagination Page 1 Next page Next › Current Legal Analysis Breaking Down Federal Policies to Address Drug Shortages by: McDermott + Consulting PPPlease Stop Fraud: Two Whistleblowers Awarded $2.5 Million in PPP Fraud Settlement by: Tycko & Zavareei Whistleblower Practice Group On July 1, 2024, Texas May Have the Strongest Consumer Data Privacy Law in the United States by: Elizabeth Rogers 10 Creative Ways for Lawyers to Repurpose Content by: Stefanie M. Marrone FDA Gets Technical on HCT/P Rules in Warning Letter to Human Tissue Company by: Dominick DiSabatino , Cortney Inman Upcoming Legal Education Events Jun 26 2024 TSCA Reform — Eight Years Later Jun 18 2024 There Is More to TSCA Reporting Than CDR: TSCA Sections 8(a), (c), (d), and (e) Jun 12 2024 Preparing for HHS’s 340B Administrative Dispute Resolution (“ADR”) Reboot – Lessons from the Field Jun 12 2024 Sponsor’s Role in Regulatory Testing — Complying with GLP Standards Print